Eloxx Pharmaceuticals, Inc. ELOX
- exaluren — Alport Syndrome Phase 2
- exaluren — Autosomal Dominant Polycystic Kidney Disease Preclinical
- ZKN-013 — Recessive Dystrophic Epidermolysis Bullosa Phase 1
- ZKN-013 — Junctional Epidermolysis Bullosa Phase 1
ribosome (1 companies · 4 programs)
Companies with an active program directed at ribosome.